Drugs of Abuse Testing Market by Product and Geography - Global Forecast and Analysis 2019-2023

The growing instances of drug abuse are compelling various governments agencies such as the US FDA, the CDC, and the Drug Enforcement Agency (DEA) impose stringent regulations pertaining to the use of drugs. Implementation of these regulations is driving the growth of the global drugs of abuse testing market. For instance, the researchers in the US are required to get approval from several organizations such as the National Institute on Drug Abuse (NIDA), the US FDA, and the DEA to procure cannabis for their research purposes. Additionally, researchers must secure additional approvals from various state government departments where the research is being conducted. These factors are expected to drive the growth of the market at a CAGR of nearly 6% during 2019-2023.

Market Overview

Increased strategic developments

Vendors in the market are focusing on improving their product offerings and innovations to expand their product portfolios and ensure the availability of drugs of abuse testing to end-users such as research laboratories and academic institutions. Other strategic developments such as new product launches, joint ventures, collaborations, investments, and partnerships, and acquisitions adopted by the vendors are expected to fuel the growth of the global drugs of abuse testing market size during the forecast period.

Manipulation of drug screening tests

There are instances of people evading tests for illicit drugs by manipulating the specimen that was supposed to be subjected to the tests. For example, the easy availability of chemicals such as laundry detergent, table salt, and toilet bowl cleaners give people the liberty to adulterate the specimens to manipulate drug screening tests. This is expected to hinder the growth of the global drugs of abuse testing market size.

Competitive Landscape

The market appears to be fairly concentrated with few players occupying the market share. Companies such as Abbott and Bio-Rad Laboratories Inc. have intensified competition. Factors such as stringent regulatory control on the procurement of cannabis and increased strategic developments will provide significant growth opportunities for drugs of abuse testing companies. Abbott, Bio-Rad Laboratories Inc., Danaher Corp., F. Hoffmann-La Roche Ltd, and Thermo Fisher Scientific Inc. are some of the major companies covered in this report.

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

Preface

Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

Market ecosystem

Market characteristics

Market segmentation analysis

PART 04: MARKET SIZING

Market definition

Market sizing 2018

Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

Bargaining power of buyers

Bargaining power of suppliers

Threat of new entrants

Threat of substitutes

Threat of rivalry

Market condition

PART 06: MARKET SEGMENTATION BY PRODUCT

Market segmentation by product

Comparison by product

Instruments - Market size and forecast 2018-2023

Consumables - Market size and forecast 2018-2023

Market opportunity by product

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

Geographic segmentation

Geographic comparison

North America - Market size and forecast 2018-2023

Europe - Market size and forecast 2018-2023

Asia - Market size and forecast 2018-2023

ROW - Market size and forecast 2018-2023

Key leading countries

Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

Market drivers

Market challenges

PART 11: MARKET TRENDS

PART 12: VENDOR LANDSCAPE

Overview

Landscape disruption

PART 13: VENDOR ANALYSIS

Vendors covered

Vendor classification

Market positioning of vendors

Abbott

Bio-Rad Laboratories Inc.

Danaher Corp.

F. Hoffmann-La Roche Ltd

Thermo Fisher Scientific Inc.

PART 14: APPENDIX

Research methodology

List of abbreviations

Definition of market positioning of vendors

List of Exhibits:

Exhibit 01: Global healthcare market
Exhibit 02: Segments of global healthcare market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2018
Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 09: Five forces analysis 2018
Exhibit 10: Five forces analysis 2023
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition - Five forces 2018
Exhibit 17: Product - Market share 2018-2023 (%)
Exhibit 18: Comparison by product
Exhibit 19: Instruments - Market size and forecast 2018-2023 ($ millions)
Exhibit 20: Instruments - Year-over-year growth 2019-2023 (%)
Exhibit 21: Consumables - Market size and forecast 2018-2023 ($ millions)
Exhibit 22: Consumables - Year-over-year growth 2019-2023 (%)
Exhibit 23: Market opportunity by product
Exhibit 24: Customer landscape
Exhibit 25: Market share by geography 2018-2023 (%)
Exhibit 26: Geographic comparison
Exhibit 27: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 28: North America - Year-over-year growth 2019-2023 (%)
Exhibit 29: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 30: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 31: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 32: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 33: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 34: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 35: Key leading countries
Exhibit 36: Market opportunity
Exhibit 37: Impact of drivers and challenges
Exhibit 38: Vendor landscape
Exhibit 39: Landscape disruption
Exhibit 40: Vendors covered
Exhibit 41: Vendor classification
Exhibit 42: Market positioning of vendors
Exhibit 43: Abbott - Vendor overview
Exhibit 44: Abbott - Business segments
Exhibit 45: Abbott - Organizational developments
Exhibit 46: Abbott - Geographic focus
Exhibit 47: Abbott - Segment focus
Exhibit 48: Abbott - Key offerings
Exhibit 49: Bio-Rad Laboratories Inc. - Vendor overview
Exhibit 50: Bio-Rad Laboratories Inc. - Product segments
Exhibit 51: Bio-Rad Laboratories Inc. - Organizational developments
Exhibit 52: Bio-Rad Laboratories Inc. - Geographic focus
Exhibit 53: Bio-Rad Laboratories Inc. - Segment focus
Exhibit 54: Bio-Rad Laboratories Inc. - Key offerings
Exhibit 55: Danaher Corp. - Vendor overview
Exhibit 56: Danaher Corp. - Business segments
Exhibit 57: Danaher Corp. - Organizational developments
Exhibit 58: Danaher Corp. - Geographic focus
Exhibit 59: Danaher Corp. - Segment focus
Exhibit 60: Danaher Corp. - Key offerings
Exhibit 61: F. Hoffmann-La Roche Ltd - Vendor overview
Exhibit 62: F. Hoffmann-La Roche Ltd - Product segments
Exhibit 63: F. Hoffmann-La Roche Ltd - Organizational developments
Exhibit 64: F. Hoffmann-La Roche Ltd - Geographic focus
Exhibit 65: F. Hoffmann-La Roche Ltd - Segment focus
Exhibit 66: F. Hoffmann-La Roche Ltd - Key offerings
Exhibit 67: Thermo Fisher Scientific Inc. - Vendor overview
Exhibit 68: Thermo Fisher Scientific Inc. - Business segments
Exhibit 69: Thermo Fisher Scientific Inc. - Organizational developments
Exhibit 70: Thermo Fisher Scientific Inc. - Geographic focus
Exhibit 71: Thermo Fisher Scientific Inc. - Segment focus
Exhibit 72: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 73: Validation techniques employed for market sizing
Exhibit 74: Definition of market positioning of vendors

Executive Summary

The following companies are recognised as the key players in the global drugs of abuse testing market: Abbott, Bio-Rad Laboratories Inc., Danaher Corp., F. Hoffmann-La Roche Ltd, and Thermo Fisher Scientific Inc.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the growth of luxury cannabis products.”

According to the report, one of the major drivers for this market is the stringent regulatory control on the procurement of cannabis.

Further, the report states that one of the major factors hindering the growth of this market is the manipulation of drug screening tests.

The study was conducted using an objective combination of primary and secondary information, including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.